Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin
$

K

FUNDED FOR RESEARCH

Choose Your Language:

Funded Research

2023

A New in Vitro Human Model to Study MOGAD Physiopathology: The MOGAXON Project

A New in Vitro Human Model to Study MOGAD Physiopathology: The MOGAXON Project

Show More
Double Seronegative NMO in Latin America: An Epidemiological Overview

Double Seronegative NMO in Latin America: An Epidemiological Overview

Show More
Hyperreflective Foci (HRF): A New Retinal Marker in NMOSD & MOGAD?

Hyperreflective Foci (HRF): A New Retinal Marker in NMOSD & MOGAD?

Show More
Latin American Consensus for the Treatment of Patients with NMOSD

Latin American Consensus for the Treatment of Patients with NMOSD

Show More
Latin American Consensus Recommendations for Management & Treatment of Adult MOGAD Patients in Clinical Practice

Latin American Consensus Recommendations for Management & Treatment of Adult MOGAD Patients in Clinical Practice

Show More
NMOSD and MOGAD in Montenegro: Clinical Aspects, Pain, and Community Impact 

NMOSD and MOGAD in Montenegro: Clinical Aspects, Pain, and Community Impact 

Show More
Thymic Negative Selection in T-cell Repertoire Development in MOG CNS Autoimmunity

Thymic Negative Selection in T-cell Repertoire Development in MOG CNS Autoimmunity

Show More
Validating the TRIPS-A Scoring Tool for Relapse Prediction in MOGAD

Validating the TRIPS-A Scoring Tool for Relapse Prediction in MOGAD

Show More

2022

Characterizing Genetic Risk Relationships in NMOSD

Characterizing Genetic Risk Relationships in NMOSD

Show More
Frequency and Burdens of Misdiagnosis in NMOSD: National Population-Based Study

Frequency and Burdens of Misdiagnosis in NMOSD: National Population-Based Study

Show More
Myelin Basic Protein as a Potential Biomarker for MOGAD

Myelin Basic Protein as a Potential Biomarker for MOGAD

Show More
NMOSD/MOGAD & Genetic Susceptibility: Differences Between Populations

NMOSD/MOGAD & Genetic Susceptibility: Differences Between Populations

Show More
Serum Biomarkers for Relapse Prediction in MOGAD

Serum Biomarkers for Relapse Prediction in MOGAD

Show More
The Implication of the Microglial Inflammasome in AQP4-IgG-Mediated Astrocytopathy

The Implication of the Microglial Inflammasome in AQP4-IgG-Mediated Astrocytopathy

Show More
Understanding the Interplay of Genetics, Metabolics and Other Non-genetic Factors Related to Patient Outcomes

Understanding the Interplay of Genetics, Metabolics and Other Non-genetic Factors Related to Patient Outcomes

Show More
Vascular Disease and Imaging Findings in NMOSD & MOGAD

Vascular Disease and Imaging Findings in NMOSD & MOGAD

Show More

2021

Blood Biomarkers Predict Cognitive Impairment in NMOSD

Blood Biomarkers Predict Cognitive Impairment in NMOSD

Show More
HLA association in Pediatric MOGAD, NMOSD and ADEM

HLA association in Pediatric MOGAD, NMOSD and ADEM

Show More
In vivo assessment of retinal vascular integrity in NMOSD and MOGAD

In vivo assessment of retinal vascular integrity in NMOSD and MOGAD

Show More
Mapping the Employment Impact of NMOSD

Mapping the Employment Impact of NMOSD

Show More
MOG IgG Titer and its association with clinical outcomes and immune profiles

MOG IgG Titer and its association with clinical outcomes and immune profiles

Show More
Observational Study of the Impact of COVID-19 of NMOSD Patients

Observational Study of the Impact of COVID-19 of NMOSD Patients

Show More
Volumetric Analysis in MOGAD, NMOSD, and MS

Volumetric Analysis in MOGAD, NMOSD, and MS

Show More

2020

Autoantibodies in NMOSD

Autoantibodies in NMOSD

Show More
Diagnostics in NMOSD

Diagnostics in NMOSD

Show More
Investigating a Relapse Biomarker in MOG

Investigating a Relapse Biomarker in MOG

Show More
Link between MOG & Cholesterol

Link between MOG & Cholesterol

Show More
Nerve Repair & Regenerative Mechanisms Related to Potential Treatment of Neurological Disorders

Nerve Repair & Regenerative Mechanisms Related to Potential Treatment of Neurological Disorders

Show More

2019

Severe NMO / MOG / Idiopathic Optic Neuritis Treatment Analysis

Severe NMO / MOG / Idiopathic Optic Neuritis Treatment Analysis

Show More
Therapeutic Response in Pediatric NMOSD

Therapeutic Response in Pediatric NMOSD

Show More

2018

Global NMO Atlas

Global NMO Atlas

Show More
Immune Tolerization

Immune Tolerization

Show More

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.